Connection

Hiroaki Mitsuya to Cell Line

Back to Details
This is a "connection" page, showing publications Hiroaki Mitsuya has written about Cell Line.
Hiroaki Mitsuya
Connection Strength
0.213
Cell Line
  1. A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nat Commun. 2021 01 28; 12(1):668.
    View in: PubMed
    Score: 0.072
  2. Potent HIV-1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein-Ligand X-ray Structural Studies. ChemMedChem. 2019 11 06; 14(21):1863-1872.
    View in: PubMed
    Score: 0.065
  3. Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants. ChemMedChem. 2018 04 23; 13(8):803-815.
    View in: PubMed
    Score: 0.059
  4. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A. 2020 07 14; 117(28):16587-16595.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.